Sumransub Nuttavut, Racila Emil, Murugan Paari, O'Brien Conner, Marette Shelly, Lassig Amy, Skubitz Keith M
Medicine, University of Minnesota, Minneapolis, USA.
Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, USA.
Cureus. 2022 Dec 31;14(12):e33187. doi: 10.7759/cureus.33187. eCollection 2022 Dec.
The presence of a fusion in a tumor is one of the most important prognostic factors in rhabdomyosarcoma. Most histologically defined alveolar rhabdomyosarcomas bear a fusion. We discuss a case that was initially thought to be a rhabdomyosarcoma but was later discovered to have an fusion. This fusion has never been reported in rhabdomyosarcoma but typically characterizes ectomesenchymal chondromyxoid tumor (ECT), a neoplasm with typically rather benign behavior. In this article, the authors discussed whether this patient's aggressive presentation represents a variation of ECT or an unusual case of rhabdomyosarcoma.
肿瘤中某种融合基因的存在是横纹肌肉瘤最重要的预后因素之一。大多数组织学定义的肺泡状横纹肌肉瘤都带有一种融合基因。我们讨论了一个病例,该病例最初被认为是横纹肌肉瘤,但后来发现有一种融合基因。这种融合基因从未在横纹肌肉瘤中报道过,但通常是外间充质软骨黏液样肿瘤(ECT)的特征,ECT是一种行为通常较为良性的肿瘤。在本文中,作者讨论了该患者的侵袭性表现是代表ECT的一种变异还是横纹肌肉瘤的一个不寻常病例。